NCT06223516 2026-03-27Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple MyelomaAbbViePhase 1 Active not recruiting60 enrolled